Mergon acquires Inmo Tech to expand healthcare manufacturing in Ireland
Mergon Group has completed its acquisition of Inmo Tech Limited, adding specialist healthcare injection moulding expertise, an experienced team and a manufacturing base in Enniscrone, Co. Sligo. The deal strengthens Mergon’s healthcare platform as the company looks to grow with medical device customers in Ireland and beyond.
Why it matters: - Mergon Group is widening its healthcare manufacturing footprint in Ireland. - The acquisition adds specialist injection moulding capability for medical device and healthcare customers. - The deal gives Mergon a stronger platform for long-term growth in a sector that depends on precision, quality and scale.
What happened: - Mergon Group completed the acquisition of Inmo Tech Limited on October 6, 2026. - Inmo Tech is based in Enniscrone, Co. Sligo. - Inmo Tech makes precision injection moulded components for the healthcare and medical device sectors. - Mergon is an engineering-led global manufacturing group with operations in Ireland, the U.S., the Czech Republic, the U.K. and Mexico. - Mergon counts Abbott, Beckman Coulter and Pfizer among its healthcare customers.
The details: - Inmo Tech adds complementary injection moulding expertise to Mergon Group. - Inmo Tech also brings an established manufacturing facility and an experienced team. - As part of Mergon Group, Inmo Tech will gain access to engineering, automation, product development, project management and global manufacturing capabilities. - Mergon designs, develops and manufactures plastic components and assemblies for automotive, healthcare and industrial customers. - Inmo Tech specializes in technical moulding and high-quality manufacturing for healthcare and medical device applications.
Between the lines: - The acquisition appears aimed at combining Inmo Tech’s niche manufacturing skills with Mergon’s broader industrial scale. - Mergon is positioning the deal as a way to deepen relationships with healthcare customers and open new growth opportunities. - Brendan Cunningham, general manager of Inmo Tech, said the deal gives the business a strong home for employees and customers while supporting continued development. - Stéphane Maravel, CEO of Mergon Group, said Inmo Tech is a strategic fit and that the combined business can build on existing strengths and support customers.
What's next: - Mergon Group will integrate Inmo Tech into its wider operations and support the business with its international resources. - The combined company is expected to pursue additional growth in healthcare manufacturing. - Mergon and Inmo Tech both point to continued investment in customer support, technical capability and manufacturing development.
The bottom line: - Mergon has added a specialized Irish healthcare manufacturer that strengthens its technical depth and growth ambitions in medical devices.
More information: Mergon Group and Inmo Tech
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Essential Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.